MHRA Issues Multiple Field Safety Notices (31 Aug – 4 Sep 2026)

The Medicines and Healthcare products Regulatory Agency (MHRA) released a set of Field Safety Notices (FSNs) for the period 31 August to 4 September 2026. These notices provide safety information for a range of medical devices and in‑vitro diagnostic reagents. - 27 August 2026 – Model: Acu‑Loc 2 VDR Plt Std L – MHRA reference 40679952 2026/008/028/601/038 - 24 August 2026 – MHRA reference 40687391 2026/008/013/601/181 (product not specified) - 11 August 2026 – General‑purpose multi‑parameter bedside monitor – MHRA reference 40686601 2026/008/005/601/078 - Ref 38018 – Patient health record information system – MHRA reference 40681769 2026/008/028/601/128 - Ref 85492 – MHRA reference 40693494 2026/008/013/601/145 (product not specified) - Ref FSN‑HME‑2026‑02‑EN – Orthopaedic prostheses cements – MHRA reference 40679488 2026/008/013/601/021 - August 2026 – MHRA reference 40697690 2026/006/025/601/076 (product not specified) - September 2026 – Imaging lesion localisation marker, external (Models 8801071, 8801074, 8801075) – MHRA reference 40709365 2026/008/028/601/055 - August 2026 – MHRA reference 40725654 2026/008/026/601/039 (product not specified) - 31 August 2026 – Aripiprazole therapeutic drug monitoring IVD, reagent – MHRA reference 40710070 2026/008/024/601/101 - Ref FSCA‑007 – Orthopaedic cement preparation/delivery kit – MHRA reference 40719475 2026/009/002/601/137 - 02 September 2026 – Peripheral artery endovascular stent‑graft – MHRA reference 40709534 2026/008/028/601/167 Stakeholders receiving an FSN from a manufacturer should act on the notice and may contact the manufacturer for further details. The MHRA list is provided for information only.